Dupilumab

dupilumab · Regeneron Pharmaceuticals, Inc. and Sanofi

Drug timelines are a Plus or Pro feature.

150 regulatory and trial events tracked for Dupilumab, covering 2017-06-02 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Results: Mechanisms of Smell Improvement With Dupilumab. [Phase 4]